Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-29

Clinical Trial Update: Human Faecal Microbiota in Type 2 Diabetes [NA]

View source ↗

Summary

Nestlé-sponsored clinical trial update on human fecal microbiota in Type 2 Diabetes. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Type 2 Diabetes, Healthy | NA | Status: COMPLETED